Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
Positive Phase 1 Study of Monepantel, CRL Given to GA Depot, FDA Rejects Tasimelteon sNDA
Neurology News Network for the week ending March 16, 2024. [WATCH TIME: 3 minutes]
EPIDYS Trial Supports Givinostat's Efficay, SRP-9001 in EMBARK Study, Eteplirsen Shows Long-Term Safety
Neurology News Network for the week ending March 9, 2024. [WATCH TIME: 3 minutes]
ATH-1105 Shows Promise as ALS Treatment, Eplontersen Granted Fast Track for ATTR Cardiomyopathy, Poor Oral Health Linked to Brain Profiles
Neurology News Network for the week ending March 1, 2024. [WATCH TIME: 3 minutes]
CGRP and Gepant Combination Safe, DNL788 Fails ALS Study, Frexalimab Promising Phase 2 Results in Relapsing MS
Neurology News Network for the week ending February 24, 2024. [WATCH TIME: 3 minutes]
Laquinimod Reduces Caudate Volume in Huntington, Assisted Reproductive Technologies Increase In-Hospital Stroke Risk, Omaveloxolone Approved in EU
Neurology News Network for the week ending February 17, 2024. [WATCH TIME: 3 minutes]
Adrenomedullin Safe in Ischemic Stroke, NfL and GFAP Levels Identified During Stroke, Fibrinogenase Improves Functional Outcomes
Neurology News Network for the week ending February 10, 2024. [WATCH TIME: 3 minutes]
Biogen Discontinues Aducanumab, CHMP Issues Negative Opinion on Ataluren, SRP-5051 Shines in MOMENTUM Study
Neurology News Network for the week ending February 3, 2024. [WATCH TIME: 3 minutes]
Cell Therapy HLCM051 Falls Short in Stroke Study, Benefits of Light Therapy in Alzheimer, IPL344 Phase 2a Data Released
Neurology News Network for the week ending January 27, 2024. [WATCH TIME: 3 minutes]
ALS Agent PrimeC Moves to Phase 3, FDA Clears IND for AB126, APOE Carrier Status Impacts ARIA
Neurology News Network for the week ending January 21, 2024. [WATCH TIME: 3 minutes]
CBD Leads to Nonseizure Improvements, AbbVie Launches 24-Hour Levodopa Infusion in EU, CNM-Au8 Improves Visual Function and Cognition
Neurology News Network for the week ending January 13, 2024. [WATCH TIME: 4 minutes]
ALS Agent CNM-Au8 Reduces NfL, Positive CLEAR-MIND Results, Decreased Learning Abilities in Narcolepsy
Neurology News Network for the week ending January 6, 2023. [WATCH TIME: 3 minutes]
Trial of Ptau Therapy ACI-35.030 Launched, Positive Data on AMT-130 in Huntington Disease, CHMP Recommends EU Approval of Omeveloxolone
Neurology News Network for the week ending December 23, 2023. [WATCH TIME: 4 minutes]
Topline Data on NE3017 Announced, Pitolisant Improves EDS in DM1, Nerivio Reduces Migraine Treatment Days
Neurology News Network for the week ending December 16, 2023. [WATCH TIME: 3 minutes]
Concomitant ASM Dosages With Stiripentol, FDA Pushes Givinostat Decision Back, Soticlestat Improves Caregiver Satisfaction
Neurology News Network for the week ending December 9, 2023. [WATCH TIME: 3 minutes]
Phase 2 Trial of Alzheimer Psychosis Initiated, FDA Declines to Lift Hold on ENTR-601-44, Levetiracetam and Clobazam With Safety Warnings
Neurology News Network for the week ending December 1, 2023. [WATCH TIME: 4 minutes]
FDA Grants BrainStorm Meeting for NurOwn, Gene Therapy Study of AB-1005 Underway, VISION Trial to Test DBS Enhancement in PD
Neurology News Network for the week ending November 25, 2023. [WATCH TIME: 4 minutes
Valbenazine Shines in Open-Label Extension, FDA Grants Breakthrough Designation to NfL Test, Tocilizumab Effective in NMOSD
Neurology News Network for the week ending November 18, 2023. [WATCH TIME: 3 minutes]
FDA Clears Modius Sleep Device, NDA Accepted for SPN-830, Zilucoplan Improves Myasthenic Fatigue
Neurology News Network for the week ending November 11, 2023. [WATCH TIME: 3 minutes]
Migraine Preventive Prescription Trends, TAK-861 Phase 1 Study in Narcolepsy, Simufilam Not Associated With ARIA-E
Neurology News Network for the week ending November 4, 2023. [WATCH TIME: 3 minutes]
Solanezumab Fails A4 Alzheimer Study, FDA Lifts Hold on FREEDOM-DM1 Trial, CMS Announces Coverages of PET Amyloid-ß Imaging
Neurology News Network for the week ending October 21, 2023. [WATCH TIME: 3 minutes]
FDA Hands CRL to Patisiran, GBA1 Parkinson Trial Initiated, Levetiracetam Effective as First-Line Treatment in IGE Syndromes
Neurology News Network for the week ending October 14, 2023. [WATCH TIME: 3 minutes]
FDA Clears High Dose Cohort of CTI-1601, SOMNUM AI Device Approved, Intracranial Pressure Monitoring and TBI
Neurology News Network for the week ending October 7, 2023. [WATCH TIME: 3 minutes]
AdComm Committee Downvotes NurOwn, ADELY01 Cleared for Trials, Axsome Pushes Back SYMPHONY Trial
Neurology News Network for the week ending September 30, 2023. [WATCH TIME: 4 minutes]
FDA Approves AIRAscore, Pimavanserin Packing Label Updated, Blarcamesine Data Released
Neurology News Network for the week ending September 23, 2023. [WATCH TIME: 3 minutes]
MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women
Neurology News Network for the week ending September 16, 2023. [WATCH TIME: 3 minutes]
CNM-Au8 Improves Survival in ALS, New Parkinson Risk Factor Identified, Pamrevlumab Falls Short in Phase 3 Study
Neurology News Network for the week ending September 9, 2023. [WATCH TIME: 3 minutes]
Cell Therapy Bemdaneprocel Meets Primary Objective, Retinal Thickness in Parkinson Disease, TERIS Study Findings Published
Neurology News Network for the week ending September 2, 2023. [WATCH TIME: 3 minutes]
DT-216 Reduces Frataxin Levels in FA, Valbenazine FDA-Approved for Huntington Chorea, EU Approves Atogepant as Migraine Preventive
Neurology News Network for the week ending August 26, 2023. [WATCH TIME: 3 minutes]
FDA Approves DaxibotulinumtoxinA for Cervical Dystonia, Genetic Parkinson Trial Announced, DBS Improves Poststroke Mobility
Neurology News Network for the week ending August 19, 2023. [WATCH TIME: 4 minutes]
Vyvgart Hytrulo Meets Primary End Point, Trial on Fibromyalgia-Type Long COVID Continues, Aspirin Increased Intracranial Bleeding in Elders
Neurology News Network for the week ending August 12, 2023. [WATCH TIME: 3 minutes]